Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
every 1 to 3 years between ages 40 and 54
Exenatide (Byetta) was the first GLP-1R agonist to be prescribed for the treatment of T2DM and is a synthetic analog of the GLP-1R agonist, Ex-4
Thyroid 19 (9), 953956
The recommendation was made on the back of research published in the New England Journal of Medicine in 2023 that included 17,604 people with cardiovascular disease about half of whom took semaglutide and half a dummy injection
Nunn, E., et al., Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism
US$ 27.65
US$ 20.20
US$ 25.92
US$ 22.89
US$ 22.12
US$ 27.06
US$ 20.56
US$ 20.84
US$ 25.05
US$ 29.34
US$ 24.26
